{
  "fields": {
    "IV期": {"desc": "是否有IV期", "options": ["是", "否"], "default": "否"},
    "复发": {"desc": "是否提到复发", "options": ["是", "否", ""], "default": "否"},
    "M1分期": {"desc": "是否有M1分期", "options": ["是", "否"], "default": "否"},
    "转移位置": {"desc": "转移位置", "options": ["肺", "肝", "骨", "脑", "其他", ""], "multi": true, "default": ""},
    "远处转移": {"desc": "是否有远处转移", "options": ["是", "否", ""], "default": "否"},
    "转移或复发": {"desc": "转移或复发", "options": ["是", "否", ""], "default": ""},
    "切缘<1mm": {"desc": "切缘<1mm", "options": ["是", "否"], "default": "否"},
    "切缘阳性": {"desc": "切缘阳性", "options": ["是", "否"], "default": "否"},
    "是否保乳": {"desc": "是否保乳", "options": ["是", "否", ""], "default": ""},
    "可再次手术": {"desc": "患者是否可再次手术", "options": ["是", "否", ""], "default": ""},
    "已行根治手术": {"desc": "是否已行根治手术", "options": ["是", "否", ""], "default": ""},
    "cTNM": {"desc": "临床分期", "options": [], "default": ""},
    "pTNM": {"desc": "病理分期", "options": [], "default": ""},
    "ypTNM": {"desc": "新辅助治疗后病理分期", "options": [], "default": ""},
    "是否腋窝清扫": {"desc": "是否腋窝清扫", "options": ["是", "否", ""], "default": ""},
    "腋窝淋巴结是否有阳性": {"desc": "腋窝淋巴结是否有阳性", "options": ["是", "否"], "default": "否"},
    "腋窝淋巴结阳性个数(术前)": {"desc": "腋窝淋巴结阳性个数(术前)", "min": 0, "max": 20, "default": "0"},
    "腋窝淋巴结阳性个数(术后)": {"desc": "腋窝淋巴结阳性个数(术后)", "min": 0, "max": 20, "default": "0"},
    "ER%": {"desc": "雌激素受体阳性细胞百分比", "min": 0, "max": 100, "default": "0"},
    "PR%": {"desc": "孕激素受体阳性细胞百分比", "min": 0, "max": 100, "default": "0"},
    "FISH": {"desc": "FISH检测", "options": ["未扩增", "扩增", ""], "default": ""},
    "Ki-67%": {"desc": "Ki-67百分比", "min": 0, "max": 100, "default": "0"},
    "Her-2免疫组化": {"desc": "HER2免疫组化评分", "options": ["0", "1+", "2+", "3+", ""], "default": ""},
    "组织学分级": {"desc": "组织学分级", "options": ["高分化", "中分化", "低分化", ""], "default": ""},
    "肿块大小CM(术前)": {"desc": "肿块大小CM(术前)", "min": 1, "max": 12, "default": "2"},
    "肿块大小CM(术后)": {"desc": "肿块大小CM(术后)", "min": 0, "max": 12, "default": "1"},
    "术前肿块大小CM(CT)": {"desc": "术前肿块大小CM(CT)", "min": 1, "max": 12, "default": ""},
    "术后肿块大小CM(CT)": {"desc": "术后肿块大小CM(CT)", "min": 0, "max": 12, "default": ""},
    "术前肿块大小CM(MRI)": {"desc": "术前肿块大小CM(MRI)", "min": 1, "max": 12, "default": ""},
    "术后肿块大小CM(MRI)": {"desc": "术后肿块大小CM(MRI)", "min": 0, "max": 12, "default": ""},
    "术前肿块大小CM(B超)": {"desc": "术前肿块大小CM(B超)", "min": 1, "max": 12, "default": ""},
    "术后肿块大小CM(B超)": {"desc": "术后肿块大小CM(B超)", "min": 0, "max": 12, "default": ""},
    "术前肿块大小CM(查体)": {"desc": "术前肿块大小CM(查体)", "min": 1, "max": 12, "default": ""},
    "术后肿块大小CM(查体)": {"desc": "术后肿块大小CM(查体)", "min": 0, "max": 12, "default": ""},
    "年龄": {"desc": "患者实际年龄", "min": 18, "max": 90, "default": "50"},
    "绝经状态": {"desc": "绝经状态", "options": ["是", "否", ""], "default": ""},
    "PS": {"desc": "躯体状态评分", "options": ["0", "1", "2", "3", "4", "5", ""], "default": ""},
    "免疫禁忌": {"desc": "免疫禁忌", "options": ["是", "否", ""], "default": ""},
    "pCR": {"desc": "新辅助治疗评价完全缓解", "options": ["是", "否", ""], "default": ""},
    "ypT0N0": {"desc": "是否能推断出ypT0N0", "options": ["是", "否", ""], "default": ""},
    "MP评分": {"desc": "Miller-Payne(MP)评分", "options": ["1", "2", "3", "4", "5", ""], "default": ""},
    "有新辅助治疗": {"desc": "有新辅助治疗", "options": ["是", "否", ""], "default": ""},
    "新辅助治疗使用免疫": {"desc": "新辅助治疗使用免疫", "options": ["是", "否", ""], "default": ""},
    "新辅助治疗使用双靶": {"desc": "新辅助治疗使用双靶", "options": ["是", "否", ""], "default": ""},
    "基因高风险": {"desc": "基因高风险", "options": ["是", "否", ""], "default": ""},
    "DFS（月）": {"desc": "无病生存期（月）", "min": 6, "max": 60, "default": ""},
    "复发时间": {"desc": "复发时间", "format": "yyyy-MM-dd", "min_year": 2010, "max_year": 2025, "default": ""},
    "根治手术时间": {"desc": "根治手术时间", "format": "yyyy-MM-dd", "min_year": 2010, "max_year": 2025, "default": ""},
    "药品信息": {
      "desc": "药品信息（可为药品明细或方案名称）",
      "type": "union",
      "options": [
        {
          "type": "list",
          "fields": [
            {"药品名称": "卡铂", "药品类别": "化疗"},
            {"药品名称": "多西他赛", "药品类别": "化疗"},
            {"药品名称": "紫杉醇", "药品类别": "化疗"},
            {"药品名称": "白蛋白紫杉醇", "药品类别": "化疗"},
            {"药品名称": "表柔比星", "药品类别": "化疗"},
            {"药品名称": "多柔比星", "药品类别": "化疗"},
            {"药品名称": "环磷酰胺", "药品类别": "化疗"},
            {"药品名称": "顺铂", "药品类别": "化疗"},
            {"药品名称": "卡培他滨", "药品类别": "化疗"},
            {"药品名称": "吉西他滨", "药品类别": "化疗"},
            {"药品名称": "长春瑞滨", "药品类别": "化疗"},
            {"药品名称": "氟尿嘧啶", "药品类别": "化疗"},
            {"药品名称": "艾立布林", "药品类别": "化疗"},
            {"药品名称": "奥拉帕利", "药品类别": "化疗"},
            {"药品名称": "贝伐珠单抗", "药品类别": "化疗"},
            {"药品名称": "依托泊苷", "药品类别": "化疗"},
            {"药品名称": "优替德隆", "药品类别": "化疗"},
            {"药品名称": "戈沙妥珠单抗", "药品类别": "化疗"},
            {"药品名称": "甲氨蝶呤", "药品类别": "化疗"},
            {"药品名称": "吡柔比星", "药品类别": "化疗"},
            {"药品名称": "多柔比星脂质体", "药品类别": "化疗"},
            {"药品名称": "紫杉醇脂质体", "药品类别": "化疗"},
            {"药品名称": "曲妥珠单抗", "药品类别": "靶向治疗"},
            {"药品名称": "拉帕替尼", "药品类别": "靶向治疗"},
            {"药品名称": "T-DM1", "药品类别": "靶向治疗"},
            {"药品名称": "帕妥珠单抗", "药品类别": "靶向治疗"},
            {"药品名称": "吡咯替尼", "药品类别": "靶向治疗"},
            {"药品名称": "奈拉替尼", "药品类别": "靶向治疗"},
            {"药品名称": "伊尼妥单抗", "药品类别": "靶向治疗"},
            {"药品名称": "T-Dxd", "药品类别": "靶向治疗"},
            {"药品名称": "图卡替尼", "药品类别": "靶向治疗"},
            {"药品名称": "马吉妥昔单抗", "药品类别": "靶向治疗"},
            {"药品名称": "阿那曲唑", "药品类别": "内分泌治疗"},
            {"药品名称": "来曲唑", "药品类别": "内分泌治疗"},
            {"药品名称": "依西美坦", "药品类别": "内分泌治疗"},
            {"药品名称": "氟维司群", "药品类别": "内分泌治疗"},
            {"药品名称": "TAM", "药品类别": "内分泌治疗"},
            {"药品名称": "托瑞米芬", "药品类别": "内分泌治疗"},
            {"药品名称": "依维莫司", "药品类别": "内分泌治疗"},
            {"药品名称": "甲地孕酮", "药品类别": "内分泌治疗"},
            {"药品名称": "甲羟孕酮", "药品类别": "内分泌治疗"},
            {"药品名称": "西达本胺", "药品类别": "内分泌治疗"},
            {"药品名称": "阿贝西利", "药品类别": "内分泌治疗"},
            {"药品名称": "哌柏西利", "药品类别": "内分泌治疗"},
            {"药品名称": "达尔西利", "药品类别": "内分泌治疗"},
            {"药品名称": "瑞波西利", "药品类别": "内分泌治疗"},
            {"药品名称": "阿培利司", "药品类别": "内分泌治疗"},
            {"药品名称": "帕博丽珠单抗", "药品类别": "免疫治疗"},
            {"药品名称": "特瑞普利单抗", "药品类别": "免疫治疗"},
            {"药品名称": "卡瑞丽珠单抗", "药品类别": "免疫治疗"},
            {"药品名称": "替雷利珠单抗", "药品类别": "免疫治疗"}
          ],
          "default": []
        },
        {
          "type": "list",
          "field": "方案名称",
          "options": [
            "TCbHP","THP","TCbH","TAC","AT","AC-T","TP","化疗 + PD-1/PD-L1 抑制剂","AI 类单药","AI+CDK4/6 抑制剂","氟维司群","OFS+AI","OFS+AI+CDK4/6 抑制剂","H","HP","T-DM1","TC+H","wTH","AC-TH","ddAC-ddT","FAC-T","FAC","X","AC","TC","TAM","OFS+TAM","吡咯替尼","奈拉替尼 + 卡培他滨","TXH","TH","NH","NX","吡咯替尼 + 卡培他滨","LX","拉帕替尼 + 曲妥珠单抗","TX","GP","GT","紫杉类单药","长春瑞滨","吉西他滨","依托泊苷","紫杉类 + 贝伐珠单抗","奥拉帕利","NP","艾立布林","优替德隆 + 卡培他滨","卡培他滨 + 贝伐珠单抗","氟维司群 + CDK4/6 抑制剂","OFS + 氟维司群","OFS + 氟维司群 + CDK4/6 抑制剂","AI + 西达本胺","AI + 依维莫司","OFS+AI + 西达本胺","孕激素","托瑞米芬","OFS + 孕激素","OFS + 托瑞米芬","OFS+AI + 依维莫司","唑来膦酸","伊班膦酸","地舒单抗","帕米磷酸二钠","XH","多西他赛","白蛋白紫杉醇","紫杉醇","TAM-AI","AC-TP","奈拉替尼","TAM+CDK4/6 抑制剂","OFS+TAM+CDK4/6 抑制剂","戈沙妥珠单抗","图卡替尼 + 卡培他滨","马吉妥昔单抗 + 化疗","T-Dxd","PD-1/PD-L1 抑制剂","大淋测试 update","H+TKI","TKI + 化疗","白蛋白紫杉醇 + 其他化疗","氟维司群 + AI","OFS + 氟维司群 + AI","骨保护","马吉妥昔单抗","阿贝西利","帕米膦酸二钠","伊尼妥单抗","TH + 吡咯替尼","TP + 帕博利珠单抗","氟维司群 + 依维莫司","阿培利司","抗 HER-2 单抗联合紫衫类为基础的其他方案如 AC-THP","蒽环联合紫衫方案：TAC、AT","科学、合理设计的临床研究如：抗 HER-2 ADC 等","以蒽环和紫衫为主的其他方案 AC-T","H + 内分泌治疗","部分乳腺短程照射 (APBI)","部分乳腺照射 (PBI)","全乳放疗 ± 瘤床加量","全乳单周超大方案","全乳放疗 ± 瘤床加量 + 区域淋巴结放疗","低复发风险患者可考虑豁免术后放疗","胸壁 ± 区域淋巴结放疗","是否延长 AI 治疗尚存争议","确定绝经者，可序贯使用 AI","未绝经者使用 TAM 或 OFS+AI","卡培他滨","H + 化疗","HP + 化疗","拉帕替尼 + 卡培他滨","甾体类 AI + 西达本胺","甾体类 AI + 依维莫司","甾体类 AI","TAM 或托瑞米芬","单药紫衫类：白蛋白紫杉醇、多西他赛、紫杉醇","单药治疗：卡培他滨、长春瑞滨、吉西他滨、依托泊苷","联合治疗：TX 方案、GT 方案、TP 方案","联合治疗：白蛋白紫杉醇 + PD-1 抑制剂、紫衫类 + 贝伐珠单抗","多柔比星脂质体","化疗 + PD-1 抑制剂","单药治疗：艾立布林、长春瑞滨、卡培他滨、吉西他滨","联合治疗：NP 方案、GP 方案、优替德隆 + 卡培他滨、NX 方案","单药治疗：白蛋白紫杉醇、戈沙妥珠单抗、依托泊苷","联合治疗：卡培他滨 + 贝伐珠单抗、白蛋白紫杉醇 + 其他化疗","全脑放疗","鞘内注射","HER-2 阳性患者，局部症状可控，可以在密切随访下考虑使用具","姑息对症支持治疗","脑转移最大径不超过 4cm，无明显占位效应 - SRS（适用于最大","全脑放疗 ± 海马回保护","fSRT","短程全脑放疗","手术切除 ± 术腔放疗","短程全脑放疗或 fSRT","全中枢放疗","胸壁 + 包括腋窝在内的区域淋巴结放疗","定期复查","内分泌治疗方案需要根据月经情况制定，请在病程管理中填写月经信","手术切除 + 术腔 SRS 或 fSRT","TP-AC 联合帕博利珠单抗","白蛋白紫杉醇 + PD-1 抑制剂","GP+PD-1 抑制剂","其他靶向药 + 内分泌"
          ],
          "default": []
        }
      ]
    }
  },
  "logic": [
    {"if": {"IV期": "是"}, "then": {"远处转移": "是"}},
    {"if": {"远处转移": "否"}, "then": {"IV期": "否"}},
    {"if": {"肿块大小CM(术前)": "exists"}, "then": {"肿块大小CM(术前)": [1, 12]}},
    {"if": {"肿块大小CM(术后)": "exists"}, "then": {"肿块大小CM(术后)": [0, 12]}},
    {"if": {"肿块大小CM(术前)": "exists", "肿块大小CM(术后)": "exists"}, "then_range": {"肿块大小CM(术后)": ["<", "肿块大小CM(术前)"]}},
    {"if": {"肿块大小CM(术前)": "exists"}, "then": {"cTNM": "auto"}},
    {"if": {"腋窝淋巴结阳性个数(术前)": "exists"}, "then": {"cTNM": "auto"}},
    {"if": {"远处转移": "是"}, "then": {"cTNM": "auto"}},
    {"if": {"复发": "是"}, "then": {"转移或复发": "是"}},
    {"if": {"远处转移": "是"}, "then": {"转移或复发": "是"}},
    {"if": {"转移或复发": "否"}, "then": {"复发": "否", "远处转移": "否"}},
    {"if": {"转移位置": "exists"}, "then": {"远处转移": "是"}},
    {"if": {"远处转移": "否"}, "then": {"转移位置": ""}},
    {"if": {"年龄": "<45"}, "then": {"绝经状态": "否"}},
    {"if": {"年龄": ">60"}, "then": {"绝经状态": "是"}},
    {"if": {"有新辅助治疗": "否"}, "then": {"新辅助治疗使用免疫": "", "新辅助治疗使用双靶": ""}},
    {"if": {"有新辅助治疗": "是"}, "then": {"新辅助治疗使用免疫": ["是", "否", ""], "新辅助治疗使用双靶": ["是", "否", ""]}},
    {"if": {"药品信息": "exists"}, "then": {"药品信息": "drug_data.xlsx"}},
    {"if": {"根治手术时间": "exists", "复发时间": "exists"}, "then": {"DFS（月）": "diff_months(根治手术时间,复发时间)"}}
  ]
} 